Last Updated: September 24, 2026

Details for New Drug Application (NDA): 020451

✉ Email this page to a colleague

NDA 020451 describes PHOTOFRIN, which is a drug marketed by Pinnacle Biolgs and is included in one NDA. It is available from one supplier. Additional details are available on the PHOTOFRIN profile page.

The generic ingredient in PHOTOFRIN is porfimer sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the porfimer sodium profile page.

Summary for 020451

Tradename:	PHOTOFRIN
Applicant:	Pinnacle Biolgs
Ingredient:	porfimer sodium
Patents:	0

Pharmacology for NDA: 020451

Mechanism of Action	Photoabsorption
Physiological Effect	Photosensitizing Activity

Suppliers and Packaging for NDA: 020451

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PHOTOFRIN	porfimer sodium	INJECTABLE;INJECTION	020451	NDA	Pinnacle Biologics, Inc.	76128-155	76128-155-75	1 VIAL in 1 BOX, UNIT-DOSE (76128-155-75) / 31.8 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	75MG/VIAL
Approval Date:	Dec 27, 1995	TE:		RLD:	No

Expired US Patents for NDA 020451

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pinnacle Biolgs	PHOTOFRIN	porfimer sodium	INJECTABLE;INJECTION	020451-001	Dec 27, 1995	⤷ Start Trial	⤷ Start Trial
Pinnacle Biolgs	PHOTOFRIN	porfimer sodium	INJECTABLE;INJECTION	020451-001	Dec 27, 1995	⤷ Start Trial	⤷ Start Trial
Pinnacle Biolgs	PHOTOFRIN	porfimer sodium	INJECTABLE;INJECTION	020451-001	Dec 27, 1995	⤷ Start Trial	⤷ Start Trial
Pinnacle Biolgs	PHOTOFRIN	porfimer sodium	INJECTABLE;INJECTION	020451-001	Dec 27, 1995	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.